Amarin (AMRN +1.6%) bucks a weak tape this morning after saying that the USPTO has issued two...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN +1.6%) bucks a weak tape this morning after saying that the USPTO has issued two patents covering the use of it's VascepaTM capsules for treating Hypertriglyceridemia. The patent issuance is part of AMRN's effort to protect the commercial potential of the drug through 2030, and it plans to list both patents in the FDA's Orange Book.